DISPATCHESSequence comparison with archived GII.17 strainsfrom GenBank suggests that the GII.17 genotype identifiedin Guangdong is a newly emerged variant, differingfrom GII.17 strains detected before 2011. The recentdetection of this new variant in samples from patientswith sporadic cases in several regions of Asia (e.g., Korea,Japan, and Taiwan) and from groundwater in Kenya(11) suggests that this variant of GII.17 has circulated ina wide range of areas in recent years. For GII.17, most(66 [83%] of 80) sequences from the GenBank databaseare restricted to region C, the short conserved sequencesof the N terminus of the capsid gene. This conservedregion has been widely used for genotyping strains (12)and phylogenetic studies (13). To include more referencestrains and to illustrate the relationship betweenGII.17 from Guangdong and other regions, we mainlyused region C for phylogenetic analyses in this study.Similarly, phylogenetic analysis based on the nearly fulllength of capsid sequences also showed that the newlyemerged GII.17 variant in Guangdong clustered withthe strains from Japan and Taiwan in 2013 and 2014and differed from GII.17 strains detected before 2011(online Technical Appendix Figure 2).In conclusion, a norovirus genotype GII.17 variantemerged in winter 2014–15 and caused outbreaks in multiplecities in Guangdong Province, China. The distributionof GII.17 genotype among patients with sporadic cases ofgastroenteritis remains unknown. In future studies, epidemiologicand virologic surveillance should be broadened tobetter clarify virologic, clinical, and epidemiologic patternsof this newly emerged norovirus.AcknowledgmentsWe gratefully acknowledge the efforts of local Centers forDisease Control and Prevention in China in the investigation andreporting of these outbreaks.This work was supported by 12th Five-Year-Major-projectsof the China Ministry of Public Health. Grant no.2012zx10004-213.Dr. Lu is a virologist at the Guangdong Provincial Institution ofPublic Health, Guangdong Provincial Center for Disease Controland Prevention. His research interest is enteric viruses.References1. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J,Parashar UD. Systematic literature review of role of noroviruses insporadic gastroenteritis. Emerg Infect Dis. 2008;14:1224–31.http://dx.doi.org/10.3201/eid1408.0711142. Payne DC, Vinje J, Szilagyi PG, Edwards KM, Staat MA,Weinberg GA, et al. Norovirus and medically attendedgastroenteritis in U.S. children. N Engl J Med. 2013;368:1121–30.http://dx.doi.org/10.1056/NEJMsa12065893. Kroneman A, Vega E, Vennema H, Vinje J, White PA, Hansman G,et al. Proposal for a unified norovirus nomenclature andgenotyping. Arch Virol. 2013;158:2059–68. http://dx.doi.org/10.1007/s00705-013-1708-54. Centers for Disease Control and Prevention. Emergence of newnorovirus strain GII.4 Sydney–United States, 2012. MMWR MorbMortal Wkly Rep. 2013;62:55.5. van Beek J, Ambert-Balay K, Botteldoorn N, Eden JS, Fonager J,Hewitt J, et al. Indications for worldwide increased norovirusactivity associated with emergence of a new variant of genotypeII.4, late 2012. Eurosurveill. 2013;18:8–9.6. Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV,Kapikian AZ, et al. Evolutionary dynamics of GII.4 norovirusesover a 34-year period. J Virol. 2009;83:11890–901.http://dx.doi.org/10.1128/JVI.00864-097. Yu Y, Yan S, Li B, Pan Y, Wang Y. Genetic diversity anddistribution of human norovirus in China (1999–2011). BiomedRes Int. 2014;2014:196169. http://dx.doi.org/10.1155/2014/1961698. Kojima S, Kageyama T, Fukushi S, Hoshino FB, Shinohara M,Uchida K, et al. Genogroup-specific PCR primers for detection ofNorwalk-like viruses. J Virol Methods. 2002;100:107–14.http://dx.doi.org/10.1016/S0166-0934(01)00404-99. Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinje J.Genotypic and epidemiologic trends of norovirus outbreaks in theUnited States, 2009 to 2013. J Clin Microbiol. 2014;52:147–55.http://dx.doi.org/10.1128/JCM.02680-1310. Shen Z, Qian F, Li Y, Hu Y, Yuan Z, Zhang J. Novelnorovirus GII.4 variant, Shanghai, China, 2012. Emerg Infect Dis.2013;19:1337–9. http://dx.doi.org/10.3201/eid1908.13002611. Kiulia NM, Mans J, Mwenda JM, Taylor MB. Norovirus GII.17predominates in selected surface water sources in Kenya.Food Environ Virol. 2014;6:221–31.12. Centers for Disease Control and Prevention. Updated norovirusoutbreak management and disease prevention guidelines.MMWR Recomm Rep. 2011;60(RR-3):1–18.13. Papaventsis DC, Dove W, Cunliffe NA, Nakagomi O, Combe P,Grosjean P, et al. Norovirus infection in children with acutegastroenteritis, Madagascar, 2004–2005. Emerg Infect Dis.2007;13:908–11. http://dx.doi.org/10.3201/eid1306.070215Address for correspondence: Li Hui, Guangdong Provincial Center forDisease Control and Prevention, No.160, Qunxian Rd, Dashi Town,Panyu District, Guangzhou City, Guangdong Province, China;email: gdcdclihui@163.com1242 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 7, July 2015
Ebola Virus Stability on Surfaces and in Fluidsin Simulated Outbreak EnvironmentsRobert Fischer, 1 Seth Judson, 1Kerri Miazgowicz, Trenton Bushmaker,Joseph Prescott, Vincent J. MunsterWe evaluated the stability of Ebola virus on surfaces andin fluids under simulated environmental conditions for theclimate of West Africa and for climate-controlled hospitals.This virus remains viable for a longer duration on surfacesin hospital conditions than in African conditions and in liquidthan in dried blood.Since March 2014, >22,000 cases of Ebola virus disease(EVD) and ≈ 9,000 deaths have been reported in WestAfrica (1). Thousands of health care professionals have beenmobilized to West Africa to assist with the ongoing outbreakof EVD (2). More than 800 Ebola virus (EBOV) infectionshave been reported in health care professionals (1).Determining the persistence of EBOV on surfaces andunder environmental conditions specific to outbreak settingsand disease-endemic areas is critical to improvingsafety practices for these health care workers (3), as wellas answering questions about EBOV transmission amongthe public (4). Researchers have experimentally assessedthe stability of other EBOV strains on plastic, glass, andsteel within dried media or guinea pig serum (5); in thedark on glass (6); and during exposure to UV light (7).However, the environmental conditions of these studies donot reflect the higher temperatures and relative humidities(RHs) in outbreak regions, or the current outbreak strain.No infectious EBOV could be found during environmentalsampling in a ward with EVD patients; however, this resultcould be more indicative of cleaning measures than actualvirus stability (8).We report stability of EBOV with a current outbreakstrain from Guinea (Makona-WPGC07) (9) on 3 clinicallyrelevant surfaces: stainless steel, plastic, and Tyvek(Dupont, Wilmington, DE, USA). We also determinedthe stability of EBOV in water, spiked human blood, andblood from infected nonhuman primates (NHPs). Theseexperiments were conducted in 2 environmental conditions,21°C, 40% RH, and 27°C, 80% RH, to simulate aclimate-controlled hospital and the environment in WestAfrica, respectively.Author affiliation: National Institutes of Health, Hamilton,Montana, USADOI: http://dx.doi.org/10.3201/eid2107.150253The StudyWe tested the stability of EBOV on 3 materials commonlyfound in an Ebola treatment unit (ETU) in West Africa:1) utility-grade (308) stainless steel washers (McMaster-Carr, Atlanta, GA, USA); 2) plastic (Teflon [polytetrafluoroethylene];McMaster-Carr); and 3) Tyvek (from the frontof a coverall). For each time point, 3 disks (4-cm diameter)of each material were placed individually into wellsof a 6-well plate. Five samples (10 μL/sample) containinga total dose of 10 6 50% tissue culture infectious doses(TCID 50s) of EBOV in cell-free medium were evenly distributedon the disks. The plates were divided into groups,and each group was placed into a plastic HEPA-filtered boxand placed at 21°C, 40% RH, or 27°C, 80% RH. The sampleswere dried naturally, and virus titers were determinedover a 14-day period.In the surface and fluid stability experiments, all sampleswere stored at −80°C until titration (1 freeze–thawcycle of EBOV samples that did not change virus titer).Titrations were performed on Vero E6 cells as described(10,11). The TCID 50per milliliter for each sample at eachtime point was calculated by using the Spearman-Karbermethod (11).Because viral decay rates often exhibit first-order kinetics(12), we log 10transformed our TCID 50calculationsto represent virus titer and used a linear regression analysis(Prism <strong>version</strong> 6.05; GraphPad, San Diego, CA, USA) todetermine the log 10reduction rate of EBOV on each surfaceat both environmental conditions (Figure 1; Table 1).We also determined whether linear regression models weresignificantly different from each other at the p
- Page 3 and 4:
July 2015SynopsisOn the CoverMarian
- Page 5 and 6:
1240 Gastroenteritis OutbreaksCause
- Page 7 and 8:
SYNOPSISDisseminated Infections wit
- Page 9 and 10:
Disseminated Infections with Talaro
- Page 11 and 12:
Disseminated Infections with Talaro
- Page 13 and 14:
Macacine Herpesvirus 1 inLong-Taile
- Page 15 and 16:
Macacine Herpesvirus 1 in Macaques,
- Page 17 and 18:
Macacine Herpesvirus 1 in Macaques,
- Page 19:
Macacine Herpesvirus 1 in Macaques,
- Page 23:
Malaria among Young Infants, Africa
- Page 26 and 27:
RESEARCHFigure 3. Dynamics of 19-kD
- Page 28 and 29:
Transdermal Diagnosis of MalariaUsi
- Page 30 and 31:
RESEARCHFigure 2. A) Acoustic trace
- Page 32 and 33:
RESEARCHof malaria-infected mosquit
- Page 34 and 35:
Lack of Transmission amongClose Con
- Page 36 and 37:
RESEARCH(IFA) and microneutralizati
- Page 38 and 39:
RESEARCHoropharyngeal, and serum sa
- Page 40 and 41:
RESEARCH6. Assiri A, McGeer A, Perl
- Page 42 and 43:
RESEARCHadvanced genomic sequencing
- Page 44 and 45:
RESEARCHTable 2. Next-generation se
- Page 46 and 47:
RESEARCHTable 3. Mutation analysis
- Page 48 and 49:
RESEARCHReferences1. Baize S, Panne
- Page 50 and 51:
Parechovirus Genotype 3 Outbreakamo
- Page 52 and 53:
RESEARCHFigure 1. Venn diagramshowi
- Page 54 and 55:
RESEARCHTable 2. HPeV testing of sp
- Page 56 and 57:
RESEARCHFigure 5. Distribution of h
- Page 58 and 59:
RESEARCHReferences1. Selvarangan R,
- Page 60 and 61:
RESEARCHthe left lobe was sampled b
- Page 62 and 63:
RESEARCHTable 2. Middle East respir
- Page 64 and 65:
RESEARCHseroprevalence in domestic
- Page 66 and 67:
RESEARCHmeasure their current surve
- Page 68 and 69:
RESEARCHTable 2. States with labora
- Page 70 and 71:
RESEARCHFigure 2. Comparison of sur
- Page 72 and 73:
RESEARCH9. Centers for Disease Cont
- Page 74 and 75:
RESEARCHthe analyses. Cases in pers
- Page 76 and 77:
RESEARCHTable 3. Sampling results (
- Page 78 and 79:
RESEARCHpresence of Legionella spp.
- Page 80 and 81:
Seroprevalence for Hepatitis Eand O
- Page 82 and 83:
RESEARCHTable 1. Description of stu
- Page 84 and 85:
RESEARCHTable 3. Crude and adjusted
- Page 86 and 87:
RESEARCHrates by gender or HIV stat
- Page 88 and 89:
RESEARCH25. Taha TE, Kumwenda N, Ka
- Page 90 and 91:
POLICY REVIEWDutch Consensus Guidel
- Page 92 and 93:
POLICY REVIEWTable 3. Comparison of
- Page 94 and 95:
POLICY REVIEW6. Botelho-Nevers E, F
- Page 96 and 97:
DISPATCHESFigure 1. Phylogenetic tr
- Page 98 and 99: DISPATCHESSevere Pediatric Adenovir
- Page 100 and 101: DISPATCHESTable 1. Demographics and
- Page 102 and 103: DISPATCHES13. Kim YJ, Hong JY, Lee
- Page 104 and 105: DISPATCHESTable. Alignment of resid
- Page 106 and 107: DISPATCHESFigure 2. Interaction of
- Page 108 and 109: DISPATCHESSchmallenberg Virus Recur
- Page 110 and 111: DISPATCHESFigure 2. Detection of Sc
- Page 112 and 113: DISPATCHESFigure 1. Histopathologic
- Page 114: DISPATCHESFigure 2. Detection of fo
- Page 117 and 118: Influenza Virus Strains in the Amer
- Page 119 and 120: Novel Arenavirus Isolates from Nama
- Page 121 and 122: Novel Arenaviruses, Southern Africa
- Page 123 and 124: Readability of Ebola Informationon
- Page 125 and 126: Readability of Ebola Information on
- Page 127 and 128: Patients under investigation for ME
- Page 129 and 130: Patients under investigation for ME
- Page 131 and 132: Wildlife Reservoir for Hepatitis E
- Page 133 and 134: Asymptomatic Malaria and Other Infe
- Page 135 and 136: Asymptomatic Malaria in Children fr
- Page 137 and 138: Bufavirus in Wild Shrews and Nonhum
- Page 139 and 140: Bufavirus in Wild Shrews and Nonhum
- Page 141 and 142: Range Expansion for Rat Lungworm in
- Page 143 and 144: Slow Clearance of Plasmodium falcip
- Page 145 and 146: Slow Clearance of Plasmodium falcip
- Page 147: Gastroenteritis Caused by Norovirus
- Page 151 and 152: Ebola Virus Stability on Surfaces a
- Page 153 and 154: Outbreak of Ciprofloxacin-Resistant
- Page 155 and 156: Outbreak of S. sonnei, South KoreaT
- Page 157 and 158: Rapidly Expanding Range of Highly P
- Page 159 and 160: Cluster of Ebola Virus Disease, Bon
- Page 161 and 162: Cluster of Ebola Virus Disease, Lib
- Page 163 and 164: ANOTHER DIMENSIONThe Past Is Never
- Page 165 and 166: Measles Epidemic, Boston, Massachus
- Page 167 and 168: LETTERSInfluenza A(H5N6)Virus Reass
- Page 169 and 170: LETTERSsystem (8 kb-span paired-end
- Page 171 and 172: LETTERS3. Van Hong N, Amambua-Ngwa
- Page 173 and 174: LETTERSTable. Prevalence of Bartone
- Page 175 and 176: LETTERSavian influenza A(H5N1) viru
- Page 177 and 178: LETTERSprovinces and a total of 200
- Page 179 and 180: LETTERS7. Manian FA. Bloodstream in
- Page 181 and 182: LETTERSforward projections. N Engl
- Page 183 and 184: LETTERS3. Guindon S, Gascuel OA. Si
- Page 185 and 186: BOOKS AND MEDIAin the port cities o
- Page 187 and 188: ABOUT THE COVERNorth was not intere
- Page 189 and 190: Earning CME CreditTo obtain credit,
- Page 191: Emerging Infectious Diseases is a p